表紙:強迫性障害治療薬市場:シェア、規模、動向、業界分析レポート、治療タイプ別、症状タイプ別、流通チャネル別、地域別、セグメント別予測、2023年~2032年
市場調査レポート
商品コード
1238757

強迫性障害治療薬市場:シェア、規模、動向、業界分析レポート、治療タイプ別、症状タイプ別、流通チャネル別、地域別、セグメント別予測、2023年~2032年

Obsessive Compulsion Disorder Drug Market Share, Size, Trends, Industry Analysis Report, By Therapy Type; By Symptoms Type; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032

出版日: | 発行: Polaris Market Research | ページ情報: 英文 117 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
強迫性障害治療薬市場:シェア、規模、動向、業界分析レポート、治療タイプ別、症状タイプ別、流通チャネル別、地域別、セグメント別予測、2023年~2032年
出版日: 2023年02月01日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の強迫性障害治療薬の市場規模は、2032年までに14億941万米ドルに達すると予測されています。

当レポートでは、世界の強迫性障害治療薬市場について調査し、製品・サービス別、治療タイプ別、症状タイプ別、流通チャネル別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の強迫性障害薬市場の洞察

  • 強迫性障害治療薬- 業界のスナップショット
  • 強迫性障害治療薬市場力学
    • 原動力と機会
    • 抑制要因と課題
  • ポーターのファイブフォース分析
  • PESTEL分析
  • 強迫性障害治療薬市場の業界動向
  • バリューチェーン分析
  • COVID-19影響分析

第5章 世界の強迫性障害治療薬市場、治療タイプ別

  • 主な調査結果
  • イントロダクション
    • 世界の強迫性障害治療薬市場、治療タイプ別、2019年~2032年(100万米ドル)
  • 強迫性障害
  • 強迫観念のチェック
  • 目に見える強迫行為のない強迫観念
  • 整頓強迫のある対称性強迫観念
  • ホーディング

第6章 世界の強迫性障害治療薬市場、症状タイプ別

  • 主な調査結果
  • イントロダクション
    • 世界の強迫性障害治療薬市場、症状タイプ別、2019年~2032年(100万米ドル)
  • 認知行動療法
  • 増強療法
  • 嫌悪療法
  • 体系的減感作
  • その他

第7章 世界の強迫性障害薬市場、流通チャネル別

  • 主な調査結果
  • イントロダクション
    • 世界の強迫性障害治療薬市場、流通チャネル別、2019年~2032年(100万米ドル)
  • 院内薬局
  • オンライン薬局
  • ドラッグストア
  • 小売薬局

第8章 世界の強迫性障害薬市場、地域別

  • 主な調査結果
  • イントロダクション
    • 強迫性障害治療薬市場評価、地域別、2019年~2032年(100万米ドル)
  • 強迫性障害治療薬市場-北米
  • 強迫性障害治療薬市場- 欧州
  • 強迫性障害治療薬市場- アジア太平洋
  • 強迫性障害治療薬市場-中東・アフリカ
  • 強迫性障害治療薬市場-ラテンアメリカ

第9章 競合情勢

第10章 企業プロファイル

  • Abbott
  • Abbvie Inc
  • Addex Pharmaceuticals Ltd
  • AstraZeneca
  • Brainsway
  • C4X discovery holdings plc
  • Eli Lilly and Company
  • F. Hoffmann-La-Roche Ltd
  • Meiji holdings Co. Ltd
  • Merck & Co. Inc
  • Mylan
  • Novartis AG
  • Omeros Corporation
  • Pfizer Inc
  • Sanofi
  • Sellas
  • Zydus Cadila
図表

List of Tables

  • Table 1 Global Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 2 Global Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 3 Global Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 4 Obsessive Compulsion Disorder Drug Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 6 North America: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 7 North America: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 8 U.S.: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 9 U.S.: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 10 U.S.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 11 Canada: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 12 Canada: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 13 Canada: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 14 Europe: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 15 Europe: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 16 Europe: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 17 UK: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 18 UK: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 19 UK: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 20 France: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 21 France: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 22 France: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 23 Germany: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 24 Germany: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 25 Germany: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 26 Italy: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 27 Italy: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 28 Italy: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 29 Spain: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 30 Spain: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 31 Spain: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 32 Netherlands: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 33 Netherlands: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 34 Netherlands: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 35 Russia: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 36 Russia: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 37 Russia: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 41 China: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 42 China: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 43 China: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 44 India: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 45 India: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 46 India: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 47 Malaysia: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 48 Malaysia: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 49 Malaysia: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 50 Japan: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 51 Japan: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 52 Japan: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 53 Indonesia: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 54 Indonesia: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 55 Indonesia: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 56 South Korea: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 57 South Korea: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 58 South Korea: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 65 UAE: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 66 UAE: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 67 UAE: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 68 Israel: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 69 Israel: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 70 Israel: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 71 South Africa: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 72 South Africa: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 73 South Africa: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 74 Latin America: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 75 Latin America: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 76 Latin America: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 77 Mexico: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 78 Mexico: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 79 Mexico: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 80 Brazil: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 81 Brazil: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 82 Brazil: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 83 Argentina: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • Table 84 Argentina: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • Table 85 Argentina: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Obsessive Compulsion Disorder Drug Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Symptoms Type
  • Figure 7. Global Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2021 & 2030 (USD Million)
  • Figure 8. Market by Therapy Type
  • Figure 9. Global Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2021 & 2030 (USD Million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2021 & 2030 (USD Million)
  • Figure 12. Obsessive Compulsion Disorder Drug Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Obsessive Compulsion Disorder Drug Market
目次
Product Code: PM3020

The global obsessive compulsive disorder market size is expected to reach USD 1,409.41 million by 2032, according to a new study by Polaris Market Research. The report "Obsessive Compulsion Disorder Market Share, Size, Trends, Industry Analysis Report, By Therapy Type; By Symptom Type; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Treatment, therapies, and innovative treatments, as well as breakthroughs in anti-anxiety, antipsychotic, and antidepressant medicines, are projected to present a variety of potential prospects in the OCD pharmaceuticals market. One of the primary factors driving the growth of the obsessive-compulsive disorder drug market in the next years will be the rising usage of off-label treatments. In addition, rising research on first-in-class peptide therapies and increasing generic approvals will result in significant market demand.

The OCD market is predicted to develop due to the high incidence of OCD and lifestyle changes that cause changes in cognitive processes. According to the International OCD Foundation, about nearly 2-3 Mn individuals in the United States suffer from the condition, it is also estimated almost 500,000 American youngsters have OCD. Many cases of OCD go unreported since many individuals are unaware of the existence of such a disorder.

The Bergen 4- Day Treatment (B4DT) is an exposure-grounded treatment administered over four days. In around 70 cases, B4DT has been demonstrated to promote quick and long-lasting absolution. This offers a foundation for exploration into the cerebral and neurobiological differences associated with remedy response and non-response. The current study will look at long-term changes in cerebral assessment and DNA methylation in B4DT cases, and a subset will also have multimodal brain imaging.

Obsessive Compulsion Disorder Drug Market Report Highlights:

  • In 2022, contamination obsessions with compulsions are expected to dominate the worldwide obsessive obsessive-compulsive disorder medication market because of advancements in therapy, therapies, and the launch of innovative treatments.
  • The market for online pharmacies is expected to increase significantly. The segmented expansion in the obsessive-compulsive disorder pharmaceuticals market may be ascribed to expanding internet penetration and the number of mobile apps.
  • North America is the dominant area, because of favorable government initiatives and increased R&D expenditure by leading market participants.
  • The global players include: Abbott, Abbvie Inc, Addex Therapeutics, AstraZeneca, Brainsway, C4X discovery, Eli Lilly and Company, Roche Ltd, Meiji holdings, Merck, Mylan, Novartis, Omeros Corporation, Pfizer, Sanofi, Sellas, and Zydus Cadila.

Polaris Market Research has segmented the obsessive compulsion disorder drug market report based on therapy type, symptoms type, distribution channel, and region:

Obsessive Compulsion Disorder Drug, Therapy Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Contamination Obsessions
  • Checking Compulsion Obsession
  • Without Visible Compulsion
  • Symmetry Obsessions with ordering Compulsions
  • Hoarding

Obsessive Compulsion Disorder Drug, Symptoms Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Cognitive Behavioral Therapy
  • Augmentation Therapy
  • Aversion Therapy
  • Systematic Desensitization
  • Others

Obsessive Compulsion Disorder Drug, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospital Pharmacy
  • Online Pharmacy
  • Drug Store
  • Retail Pharmacy

Obsessive Compulsion Disorder Drug, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Obsessive Compulsion Disorder Drug Market Insights

  • 4.1. Obsessive Compulsion Disorder Drug - Industry Snapshot
  • 4.2. Obsessive Compulsion Disorder Drug Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Discovery of new medications to treat obsessive-compulsive disorder
      • 4.2.1.2. increased acceptance of off-label medications in conjunction with authorized therapy
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Adverse effects of drugs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Obsessive Compulsion Disorder Drug Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Obsessive Compulsion Disorder Drug Market, by Therapy Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
  • 5.3. Contamination Obsession
    • 5.3.1. Global Obsessive Compulsion Disorder Drug Market, by Contamination Obsession, by Region, 2019-2032 (USD Million)
  • 5.4. Checking Compulsions
    • 5.4.1. Global Obsessive Compulsion Disorder Drug Market, by Checking Compulsions, by Region, 2019-2032 (USD Million)
  • 5.5. Obsessions without Visible Compulsions
    • 5.5.1. Global Obsessive Compulsion Disorder Drug Market, by Obsessions without Visible Compulsions, by Region, 2019-2032 (USD Million)
  • 5.6. Symmetry Obsessions with ordering compulsions
    • 5.6.1. Global Obsessive Compulsion Disorder Drug Market, by Symmetry Obsessions with ordering compulsions, by Region, 2019-2032 (USD Million)
  • 5.7. Hoarding
    • 5.7.1. Global Obsessive Compulsion Disorder Drug Market, by Hoarding, by Region, 2019-2032 (USD Million)

6. Global Obsessive Compulsion Disorder Drug Market, by Symptoms Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • 6.3. Cognitive Behavioural Therapy
    • 6.3.1. Global Obsessive Compulsion Disorder Drug Market, by Cognitive Behavioural Therapy, by Region, 2019-2032 (USD Million)
  • 6.4. Augmentation Therapy
    • 6.4.1. Global Obsessive Compulsion Disorder Drug Market, by Augmentation Therapy, by Region, 2019-2032 (USD Million)
  • 6.5. Aversion Therapy
    • 6.5.1. Global Obsessive Compulsion Disorder Drug Market, by Aversion Therapy, by Region, 2019-2032 (USD Million)
  • 6.6. Systematic Desensitization
    • 6.6.1. Global Obsessive Compulsion Disorder Drug Market, by Systematic Desensitization, by Region, 2019-2032 (USD Million)
  • 6.7. Others
    • 6.7.1. Global Obsessive Compulsion Disorder Drug Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Obsessive Compulsion Disorder Drug Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • 7.3. Hospital Pharmacy
    • 7.3.1. Global Obsessive Compulsion Disorder Drug Market, by Hospital Pharmacy, By Region, 2019-2032 (USD Million)
  • 7.4. Online Pharmacy
    • 7.4.1. Global Obsessive Compulsion Disorder Drug Market, by Online Pharmacy, By Region, 2019-2032 (USD Million)
  • 7.5. Drug Store
    • 7.5.1. Global Obsessive Compulsion Disorder Drug Market, by Drug Store, By Region, 2019-2032 (USD Million)
  • 7.6. Retail Pharmacy
    • 7.6.1. Global Obsessive Compulsion Disorder Drug Market, by Retail Pharmacy, By Region, 2019-2032 (USD Million)

8. Global Obsessive Compulsion Disorder Drug Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Obsessive Compulsion Disorder Drug Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Obsessive Compulsion Disorder Drug Market - North America
    • 8.3.1. North America: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.3.3. North America: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.3.4. Obsessive Compulsion Disorder Drug Market - U.S.
      • 8.3.4.1. U.S.: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.3.5. Obsessive Compulsion Disorder Drug Market - Canada
      • 8.3.5.1. Canada: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • 8.4. Obsessive Compulsion Disorder Drug Market - Europe
    • 8.4.1. Europe: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.3. Europe: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.4.4. Obsessive Compulsion Disorder Drug Market - UK
      • 8.4.4.1. UK: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.4.5. Obsessive Compulsion Disorder Drug Market - France
      • 8.4.5.1. France: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.5.3. France: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.4.6. Obsessive Compulsion Disorder Drug Market - Germany
      • 8.4.6.1. Germany: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.4.7. Obsessive Compulsion Disorder Drug Market - Italy
      • 8.4.7.1. Italy: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.4.8. Obsessive Compulsion Disorder Drug Market - Spain
      • 8.4.8.1. Spain: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.4.9. Obsessive Compulsion Disorder Drug Market - Netherlands
      • 8.4.9.1. Netherlands: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.4.10. Obsessive Compulsion Disorder Drug Market - Russia
      • 8.4.10.1. Russia: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • 8.5. Obsessive Compulsion Disorder Drug Market - Asia Pacific
    • 8.5.1. Asia Pacific: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.5.4. Obsessive Compulsion Disorder Drug Market - China
      • 8.5.4.1. China: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.4.3. China: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.5.5. Obsessive Compulsion Disorder Drug Market - India
      • 8.5.5.1. India: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.5.3. India: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.5.6. Obsessive Compulsion Disorder Drug Market - Malaysia
      • 8.5.6.1. Malaysia: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.5.7. Obsessive Compulsion Disorder Drug Market - Japan
      • 8.5.7.1. Japan: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.5.8. Obsessive Compulsion Disorder Drug Market - Indonesia
      • 8.5.8.1. Indonesia: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.5.9. Obsessive Compulsion Disorder Drug Market - South Korea
      • 8.5.9.1. South Korea: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • 8.6. Obsessive Compulsion Disorder Drug Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.6.4. Obsessive Compulsion Disorder Drug Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.6.5. Obsessive Compulsion Disorder Drug Market - UAE
      • 8.6.5.1. UAE: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.6.6. Obsessive Compulsion Disorder Drug Market - Israel
      • 8.6.6.1. Israel: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.6.7. Obsessive Compulsion Disorder Drug Market - South Africa
      • 8.6.7.1. South Africa: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
  • 8.7. Obsessive Compulsion Disorder Drug Market - Latin America
    • 8.7.1. Latin America: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.7.4. Obsessive Compulsion Disorder Drug Market - Mexico
      • 8.7.4.1. Mexico: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.7.5. Obsessive Compulsion Disorder Drug Market - Brazil
      • 8.7.5.1. Brazil: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
    • 8.7.6. Obsessive Compulsion Disorder Drug Market - Argentina
      • 8.7.6.1. Argentina: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott
    • 10.1.1. Company Overview
    • 10.1.2. Financial PerSymptoms Typeance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Abbvie Inc
    • 10.2.1. Company Overview
    • 10.2.2. Financial PerSymptoms Typeance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Addex Pharmaceuticals Ltd
    • 10.3.1. Company Overview
    • 10.3.2. Financial PerSymptoms Typeance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. AstraZeneca
    • 10.4.1. Company Overview
    • 10.4.2. Financial PerSymptoms Typeance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Brainsway
    • 10.5.1. Company Overview
    • 10.5.2. Financial PerSymptoms Typeance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. C4X discovery holdings plc
    • 10.6.1. Company Overview
    • 10.6.2. Financial PerSymptoms Typeance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Eli Lilly and Company
    • 10.7.1. Company Overview
    • 10.7.2. Financial PerSymptoms Typeance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. F. Hoffmann-La-Roche Ltd
    • 10.8.1. Company Overview
    • 10.8.2. Financial PerSymptoms Typeance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Meiji holdings Co. Ltd
    • 10.9.1. Company Overview
    • 10.9.2. Financial PerSymptoms Typeance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Merck & Co. Inc
    • 10.10.1. Company Overview
    • 10.10.2. Financial PerSymptoms Typeance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Mylan
    • 10.11.1. Company Overview
    • 10.11.2. Financial PerSymptoms Typeance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Novartis AG
    • 10.12.1. Company Overview
    • 10.12.2. Financial PerSymptoms Typeance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Omeros Corporation
    • 10.13.1. Company Overview
    • 10.13.2. Financial PerSymptoms Typeance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Pfizer Inc
    • 10.14.1. Company Overview
    • 10.14.2. Financial PerSymptoms Typeance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Sanofi
    • 10.15.1. Company Overview
    • 10.15.2. Financial PerSymptoms Typeance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. Sellas
    • 10.16.1. Company Overview
    • 10.16.2. Financial PerSymptoms Typeance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development
  • 10.17. Zydus Cadila
    • 10.17.1. Company Overview
    • 10.17.2. Financial PerSymptoms Typeance
    • 10.17.3. Product Benchmarking
    • 10.17.4. Recent Development